Molecular Imaging: Page 5

FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment

By Claudia Tschabuschnig

A Dutch study found that adding metabolic imaging to contrast-enhanced CT improved early detection of local tumor progression after liver ablation or resection, including disease missed by CT alone.

July 30, 2026

Scottish team designs 10-year sustainability model for preclinical imaging

By Claudia Tschabuschnig

A Scottish team has designed a theoretical 10-year strategy for keeping a multimodal preclinical imaging facility financially viable, operationally resilient, environmentally responsible, and accessible to researchers.

July 29, 2026

ESMI review maps cancer biology ahead of TOPIM 2026

By Claudia Tschabuschnig

Ahead of TOPIM 2026, a new Nature Reviews Cancer article explores how molecular imaging can reveal the biological processes driving tumor growth, resistance, and immune evasion.

July 28, 2026

ITM launches new oncology therapeutics division

By AuntMinnie.com staff writers

Lumara Bio will focus resources toward commercial readiness for ITM's lead drug candidate, lutetium-177 (Lu-177) edotreotide (ITM-11).

July 27, 2026

SPECT/CT viable over PET/CT for high-risk prostate cancer staging

By Will Morton

Considering its broader accessibility, Tc-99m MIP-1404 CZT SPECT/CT may represent a practical alternative for primary staging.

July 24, 2026

CT dose, not FDG, drives chromosome damage during PET/CT

By Claudia Tschabuschnig

The findings suggest that standard-dose CT should be reserved for clearly justified diagnostic indications.

July 22, 2026

Spectrum Dynamics expands Veriton SPECT/CT line

By AuntMinnie.com staff writers

The company has unveiled an all-energy enhancement for its CT-400 series digital SPECT/CT scanner.

July 20, 2026

European guideline aims to harmonize bone sarcoma imaging

By Claudia Tschabuschnig

Rare bone cancers have lacked a common imaging framework across pediatric and adult care.

July 20, 2026

Tau PET tracer flags early Alzheimer risk in healthy older adults

By Will Morton

Few studies have investigated how F-18 PI-2620 is associated with memory performance or AD-related biomarkers in cognitively unimpaired older adults.

July 17, 2026

Actineer completes Ra-226 recycling process to support Ac-225 supply

By AuntMinnie.com staff writers

This process aims to improve Ac-225 supply predictability and cost stability, as well as reduce waste generation.

July 14, 2026

New PET tracer show promise in neuroblastoma

By Will Morton

F-18 mFBG achieved a pooled sensitivity of 97%, compared with 82% for I-123 MIBG.

July 9, 2026

PET/MRI can reduce the need for biopsies in prostate cancer

By Will Morton

Prostate biopsies are associated with considerable morbidity, including pain, rectal bleeding, prostatitis, and urinary tract infections.

July 2, 2026

Previous Page

Page 5 of 132

Next Page